Innovative MedTech (Innovative MedTech) EBIT : $-1.92 Mil (TTM As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Innovative MedTech EBIT?

Innovative MedTech's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was $-0.87 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was $-1.92 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Innovative MedTech's annualized ROC % for the quarter that ended in Mar. 2024 was -61.75%. Innovative MedTech's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -508.24%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Innovative MedTech's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -11.33%.

Innovative MedTech EBIT Historical Data

The historical data trend for Innovative MedTech's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innovative MedTech EBIT Chart

Innovative MedTech Annual Data

Trend

Oct09

Oct10

Oct11

Oct12

Oct13

Oct14

Jun20

Jun21

Jun22

Jun23

EBIT

Get a 7-Day Free Trial

-0.21

-0.28

-3.09

-17.87

-3.43

Innovative MedTech Quarterly Data
	Jan14	Apr14	Jul14	Oct14	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT	Get a 7-Day Free Trial															-0.75	-0.80	-0.12	-0.13	-0.87

Competitive Comparison of Innovative MedTech's EBIT

For the Medical Instruments & Supplies subindustry, Innovative MedTech's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Innovative MedTech's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Innovative MedTech's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Innovative MedTech's EV-to-EBIT falls into.

Innovative MedTech EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.92 Mil.

Innovative MedTech (OTCPK:IMTH) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Innovative MedTech's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

	ROC % (Q: Mar. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2023 )	+	Invested Capital (Q: Mar. 2024 ))	/ count )
=	-3.608 * ( 1 - 0% )	/	( (5.873	+	5.812)	/ 2 )
=	-3.608	/	5.8425
=	-61.75 %

where

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	4.33	-	1.959	-	( 0.093	-	max(0, 3.8	-	0.298	+	0.093	))
=	5.873

	Invested Capital		(Q: Mar. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	4.659	-	2.105	-	( 0.104	-	max(0, 3.946	-	0.688	+	0.104	))
=	5.812

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Innovative MedTech's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2023		Q: Mar. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-3.484	/	( ( (0.713 + max(-1.983, 0))	+	(0.658 + max(-1.72, 0)) )	/	2 )
=	-3.484	/	( ( 0.713	+	0.658 )	/	2 )
=	-3.484	/	0.6855
=	-508.24 %

where Working Capital is:

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.196	+	0	+	0)	-	(1.959	+	0	+	0.22)
=	-1.983

	Working Capital		(Q: Mar. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.221	+	0	+	0.354)	-	(2.105	+	0	+	0.19)
=	-1.72

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Innovative MedTech's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2024 )
	=	-1.92	/	16.943
	=	-11.33 %

Innovative MedTech EBIT Related Terms

Thank you for viewing the detailed overview of Innovative MedTech's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Innovative MedTech (Innovative MedTech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Innovative MedTech Inc (OTCPK:IMTH) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

2310 York Street, Suite 200, Blue Island, IL, USA, 60406

Website

https://www.innovativemedtech.com

Innovative MedTech Inc is a provider of health and wellness services. It develops, manufactures, and sells a variety of medical devices and supplies, including blood collection and infusion products, surgical instruments, and wound care products. The company operates in two divisions: the RX Vitality digital wallet and health care app.

Executives

Merle Griff	officer: Chief Executive Officer	2310 YORK ST, SUITE 200, BLUE ISLAND IL 60406
Eddie Dovner	10 percent owner	70 SE 4TH AVE, DELRAY BEACH FL 33483
Charles Everhardt	director, 10 percent owner, other: Chairman of the Board	2310 YORK ST, STE 200, BLUE ISLAND IL 60406
Arthur Friedman	10 percent owner	280 MADISON AVE #1007, NEW YORK NY 10016
Marcia Roberts	10 percent owner	280 MADISON AVENUE, SUITE 1005, NEW YORK NY 10016
Michael Jordan Friedman	director, 10 percent owner, officer: President & CEO	280 MADISON AVENUE, SUITE 1005, NEW YORK NY 10016
Illuminate, Inc.	10 percent owner	881 KENNEDY BLVD., JERSEY CITL NJ 07002
A William Bodine	director, officer: CFO	280 MADISON AVENUE, SUITE 1005, NEW YORK NY 10016
Dominick M Cingari	director, officer: COO	280 MADISON AVENUE, SUITE 1005, NEW YORK NY 10016
Jay Odintz	director	280 MADISON AVENUE, NEW YORK NY 10016
Vincent L Verdiramo	director, officer: President	3163 KENNEDY BLVD, JERSEY CITY NJ 07306